Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Status:

Closed to Accrual

III

Phase

Adjuvant

Line of Therapy

Early Cancer

Disease Stage

Biomarker(s)

ER+, HER2-

Investigational

Product

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane

Treatment Arms

o Experimental: Arm II (endocrine therapy)

o Experimental: Arm I (chemotherapy and endocrine therapy)